本临床试验的目标是了解 SUPPORT+（一款数码症状监测及自我管理手机应用程式）能否改善接受姑息治疗的晚期癌症成年患者的健康相关生活质量及临床结局。 本研究旨在回答的主要问题包括： * 与常规姑息治疗相比，使用 SUPPORT+ 是否有助维持或改善健康相关生活质量？ * SUPPORT+ 能否减少功能衰退
适应症：Palliative Care、Advanced Cancer
入组条件
纳入标准
- Adults aged 18 years or older
- Diagnosis of advanced malignancy
- Decision not to pursue further systemic anticancer treatment
- Receiving follow-up care at a participating palliative care clinic
- Community-dwelling
- Ownership of a smartphone
- Adequate cognitive capacity to provide informed consent
- Willingness to receive notifications from the SUPPORT+ mobile application
- Presence of at least one symptom related to advanced cancer
- Ability for the patient or a designated primary caregiver to use the mobile application
排除标准
- Receiving systemic anticancer therapy with radical or palliative intent
- Estimated life expectancy of less than 3 months
- Eastern Cooperative Oncology Group (ECOG) performance status greater than 3
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。